Christian Rolfo, MD, PhD, of Mount Sinai Medical Center (now at Ohio State as Chief of Oncology), explores the science and clinical applications of liquid biopsies, including circulating tumor DNA. On this special Healthcare Unfiltered episode, he explains how this cutting-edge approach compares to traditional tissue samples in terms of concordance, sensitivity, and specificity, and expands on the methods used to distinguish signal from noise in liquid biopsy results.
Dr. Rolfo discusses which thoracic patients should receive liquid biopsies and the optimal timing within their care journey. He also covers the clinical decisions informed by liquid biopsy data, such as advising on adjuvant therapy, and debates the potential role of liquid biopsies in screening and early detection for healthy individuals.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
